Enrollment & Site Intelligence for Rare Disease Trials
Independent enrollment stress testing and US site intelligence for SCD gene therapy programs
Enrollment timeline stress test (best / base / worst scenarios)
Screen failure & site-count sensitivity analysis
Ranked US SCD site shortlist with activation tiering
Independent enrollment stress testing and US site intelligence for SCD and rare disease programs. Delivered as a structured feasibility memo.
Independent clinical feasibility intelligence for rare disease programs.© 2026 Zonra Bio. All rights reserved.